Safety and Efficacy of Everolimus Transition in Minimizing Progressive Graft Dysfunction and Interstitial Fibrosis in Adult Kidney Transplant Recipients
Phase of Trial: Phase IV
Latest Information Update: 31 Jul 2019
Price : $35 *
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate mofetil; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 31 Jul 2019 Results published in the Clinical Transplantation
- 26 May 2017 Status changed from active, no longer recruiting to completed.
- 18 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Jan 2017.